XGEVA for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 32 adverse event reports in the FDA FAERS database where XGEVA was used for Prostate cancer.
Most Reported Side Effects for XGEVA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 309 | 29.7% | 309 | 24 |
| Osteonecrosis of jaw | 159 | 15.3% | 5 | 14 |
| Investigation | 115 | 11.0% | 11 | 115 |
| Hospitalisation | 77 | 7.4% | 4 | 77 |
| Hypocalcaemia | 48 | 4.6% | 7 | 34 |
| Metastases to bone | 30 | 2.9% | 3 | 2 |
| Pain | 28 | 2.7% | 2 | 9 |
| Pain in extremity | 17 | 1.6% | 1 | 5 |
| Dyspnoea | 16 | 1.5% | 5 | 9 |
| Disease progression | 15 | 1.4% | 6 | 4 |
| Terminal state | 14 | 1.3% | 0 | 2 |
| Back pain | 13 | 1.3% | 0 | 2 |
| Fatigue | 13 | 1.3% | 1 | 4 |
| Hypoaesthesia | 13 | 1.3% | 5 | 6 |
| Malaise | 13 | 1.3% | 2 | 6 |
Other Indications for XGEVA
Metastases to bone (412)
Prophylaxis (385)
Product used for unknown indication (349)
Prostate cancer metastatic (25)
Breast cancer metastatic (24)
Breast cancer (23)
Bone disorder (7)
Osteoporosis (6)
Neoplasm malignant (5)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)